K Tobal
Overview
Explore the profile of K Tobal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jovanovic J, Ivey A, Vannucchi A, Lippert E, Oppliger Leibundgut E, Cassinat B, et al.
Leukemia
. 2013 Jul;
27(10):2032-9.
PMID: 23860450
Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has been no...
2.
Pennycuick A, Simpson T, Crawley D, Lal R, Santis G, Cane P, et al.
Int J Clin Pract
. 2012 Jul;
66(8):748-752.
PMID: 22805266
Aims: Epidermal growth factor receptor (EGFR) antagonists are particularly active in non-small cell lung cancer (NSCLC) patients with tumours bearing mutations in the EFGR gene. EGFR mutation prevalence is very...
3.
Ostergaard M, Nyvold C, Jovanovic J, Andersen M, Kairisto V, Morgan Y, et al.
Leukemia
. 2011 Apr;
25(7):1168-73.
PMID: 21494256
Quantitative PCR (qPCR) for detection of fusion transcripts and overexpressed genes is a promising tool for following minimal residual disease (MRD) in patients with hematological malignancies. Its widespread clinical use...
4.
Osborne D, Frost L, Tobal K, Liu Yin J
Bone Marrow Transplant
. 2005 May;
36(1):67-70.
PMID: 15908982
Relapse postautograft in acute myeloid leukaemia (AML), may in part arise from leukaemia cells present in the bone marrow (BM) inoculum, and the level of minimal residual disease (MRD) in...
5.
Tobal K, Moore H, Macheta M, Yin J
Leukemia
. 2001 Jul;
15(7):1060-5.
PMID: 11455974
Qualitative RT-PCR methods used for monitoring minimal residual disease (MRD) in APL patients fail to predict relapse in up to 25% of patients in remission. We report here the development...
6.
7.
Tobal K, Newton J, Macheta M, Chang J, Morgenstern G, Evans P, et al.
Blood
. 2000 Jan;
95(3):815-9.
PMID: 10648391
One of the most common translocations in acute myeloid leukemia (AML) is the t(8;21), which produces the fusion gene AML1-MTG8. We have developed a sensitive competitive reverse transcriptase-polymerase chain reaction...
8.
9.
Tobal K, Liu Yin J
Leukemia
. 1998 Sep;
12(9):1349-54.
PMID: 9737682
RT-PCR methods have been developed, to date, by various groups to amplify the PML-RARA fusion gene produced by the t(15;17) in APL patients. However, these methods lack the necessary sensitivity...
10.
Tobal K, Liu Yin J
Leuk Lymphoma
. 1998 Aug;
31(1-2):115-20.
PMID: 9720721
The t(8;21) is one of the most common translocations in acute myeloid leukaemia (AML) occurring in approximately 20% of adult and 40% of paediatric AML-M2. This translocation fuses the AML1...